The incidence of nontuberculous mycobacterial infections caused by Mycobacterium avium complex (NTM-MAC) have increased dramatically in recent decades, while the 5-year survival of patients with NTM-MAC infections remains similar to that of patients with lung cancer. Diagnoses are often delayed due to the nonspecific presentation of NTM-MAC and radiological findings that overlap with other pulmonary diseases. NTM-MAC treatment is also difficult with the use of multiple antibiotic regimens and frequency of refractory disease. In recent years, the availability of amikacin liposome inhalation suspension (ALIS) has provided another option for patients with NTM-MAC who do not achieve a negative sputum culture after a minimum of six consecutive months of a multidrug regimen therapy.
This activity, “Management Strategies for Mycobacterium Avium Complex Infections: Diagnosis and Treatment of a Growing Health Threat” will provide pulmonologists with expert-led discussions of guideline-based diagnosis and treatment of NTM to improve clinician skill in identifying early clinical signs of NTM-MAC, diagnosis, treatment selection, and effective communication with patients regarding NTM-MAC management
Jointly provided by the Potomac Center for Medical Education and Rockpointe
Patient resources provided by:
This activity is supported by an Educational Grant from Insmed.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Mycobacterium Avium Complex: Guideline-based Management for a Deadly and Increasingly Prevalent Disease (Regionals)
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.